Neuromyelitis Optica Spectrum Disorders
Conditions
Interventions
Effective treatment group:NONE
Ineffective treatment group:NONE
Sponsors
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1) Meets the diagnostic criteria for NMOSD proposed in the 2015 NMOSD international consensus; 2) After admission and comprehensive evaluation, IVMP and/or IVIG treatment will be given, with an initial dose of 1g/d or 0.5g/d for IVMP, which will be halved every three days; 3) Within 24 hours after admission, complete venous blood collection and Lumbar puncture before treatment, and submit blood samples and cerebrospinal fluid samples for examination; 4) Clinical data such as imaging and biochemical indicators are complete; 5) Sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1) Patients receiving acute phase treatment such as IVMP and IVIG within 3 months prior to admission; 2) Patients with severe liver and kidney dysfunction; 3) Patients with a history of concomitant malignant tumors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| serum albumin,S-Alb; | — |
Countries
China
Contacts
Public ContactYangtai Guan
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
Outcome results
None listed